Chang Kai Soh
Agency for Science, Technology and Research(SG)Institute of Molecular and Cell Biology(SG)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Chronic Lymphocytic Leukemia Research, Histone Deacetylase Inhibitors Research, Fungal Biology and Applications, Click Chemistry and Applications
Most-Cited Works
- → Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma(2018)76 cited
- → Structure and Ligand-Based Design of mTOR and PI3-Kinase Inhibitors Leading to the Clinical Candidates VS-5584 (SB2343) and SB2602(2014)29 cited
- → Structure-based optimization of morpholino-triazines as PI3K and mTOR inhibitors(2011)20 cited
- → Synthesis and biological evaluation of 6-phenylpurine linked hydroxamates as novel histone deacetylase inhibitors(2020)18 cited
- → Structure-based design of PDK1 inhibitors(2011)12 cited
- → 2-Anilino-4-aryl-8H-purine derivatives as inhibitors of PDK1(2012)11 cited